The global automated blood processing equipment market, valued at approximately USD 44,050.0 million at the end of 2021, is poised for significant growth over the next decade. According to recent projections, the market is expected to register a robust Compound Annual Growth Rate (CAGR) of 6.68%, ultimately reaching a valuation of USD 89,823.4 million by 2032.
This growth can be attributed to several factors, including the increasing demand for efficient blood processing technologies, advancements in automation, and a rising prevalence of blood-related diseases. Healthcare institutions are increasingly adopting automated systems to enhance the accuracy and efficiency of blood processing, which is essential for improving patient outcomes.
As the market continues to evolve, key players are focusing on innovation and the development of advanced blood processing solutions to meet the growing needs of healthcare providers. The integration of artificial intelligence and machine learning into blood processing equipment is also expected to drive market expansion.
Industry stakeholders are encouraged to leverage these growth opportunities as the automated blood processing equipment market presents significant potential for investment and development in the coming years.
What are the Major Drivers Boosting the Demand for Automated Blood Processing Equipment Market?
The primary drivers of the market expansion over the forecast period include an increase in demand for blood components of safer and higher quality, rising rates of chronic diseases, vigorous campaigning for blood donation programmes, and rising healthcare expenditures.
The growth of donor screening test kits and technological improvements both significantly contribute to the rising demand for automated blood equipment. Changes in the way blood is collected and the progressive switch from manual to automated blood processing are all expected to have a positive impact on market expansion.
In order to integrate the market in developing economies, the leading manufacturers in the market are also expanding the value chain. The need for automated blood processing equipment is being driven by rising healthcare expenditures and government investments in healthcare facilities in the majority of developed countries.
Key Players
Immucor; JMS Singapore Pte Ltd; MOELCA; LMB Technologie GmbH; Delcon SRL.; Baxter Healthcare; Macopharma; Grifols; Beckman Coulter, Inc; Fresenius Kabi AG; Terumo Corporation
Key Segments Covered in the Automated Blood Processing Equipment Market Survey
By Product Type:
- Automatic Blood Separator
- Automatic Blood Processing System
By End-User:
- Hospitals
- Blood banks
- Pathology Laboratory
- Ambulatory Surgical Centres
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
